Exact preoperative diagnosis is difficult to achieve and they might mimic pathologies of surrounding organs or structures because of their atypical presentation
I understand that some people may actually benefit from the drug, but not everyone. With people who could have serious reactions like Niscior and McMartin, Beivide argues it is time to introduce safeguards to make sure the drugs only get into the hands of those who really need them
In December 2025, Eli Lilly announced topline results from the phase-3 TRIUMPH-4 clinical trial evaluating the safety and efficacy of retatrutide in adults with obesity or overweight and knee osteoarthritis, and without diabetes, as an adjunct to healthy diet and physical activity
Bab I, Gavish H, Namdar-Attar M, Muhlrad A, Greenberg Z, Chen Y, et al
doi:10.3389/fneur.2021.751736 Spencer TJ, Brown A, Seidman LJ, et al
Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants
